Lophora ApS

Private limited companyCVR 39871033HerlevActive

Lophora ApS is a private limited company, based in Herlev, active in research and experimental development on natural sciences and engineering, founded in 2018. Equity was negative at the end of 2025 (−DKK 7.1m). The company made a loss in both 2024 and 2025, most recently DKK 10.9m. 7 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 11.7m−506.2% vs. 2024
Net profit−DKK 10.9m−488.6% vs. 2024
Equity−DKK 7.1m−284.4% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 1.9m to DKK 10.9m (2024 → 2025).
  • Equity turned negative: −DKK 7.1m (2024 → 2025).

Employees

  • 2 more employees than a year earlier: 5 (07/2026) against 3 (07/2025).

Management and owners, last 24 months

  • New owners registered: Anders Asbjørn Jensen (16/12/2024), Emil Märcher-Rørsted (16/12/2024) and Jesper Langgaard Kristensen (16/12/2024).
  • No longer registered as owner: Anders Asbjørn Jensen (15/12/2024), Emil Märcher-Rørsted (15/12/2024) and Jesper Langgaard Kristensen (15/12/2024).

Registrations, last 24 months

  • 02/03/2026: Moved to Herlev Hovedgade 195A, 2730 Herlev
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 16/12/2024: Share capital changed from 51,436 DKK to 63,313 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 16m−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4m202020212022202320242025
EquityNet profit
Financial figures for Lophora ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−5,402−5,530−3,610−4,168−1,923−11,655−506.2%
Operating profit (EBIT)––−5,287−5,162−2,630−12,829−387.7%
Profit before tax−6,418−8,569−6,057−6,223−2,332−13,686−486.9%
Net profit−4,947−6,391−4,311−5,385−1,856−10,925−488.6%
Total assets4,6825,9134,1653,16217,7986,538−63.3%
Equity−2,613−9,004−13,315−15,1603,842−7,084−284.4%
Liabilities7,29514,91717,47918,32213,95613,622−2.4%
Cash and cash equivalents3,0071,8922,2461,79313,6843,459−74.7%
Average number of employees333212+100%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 7.1m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Lophora ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202424/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202304/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202210/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202111/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202014/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01234508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 11.7mNo. 396 of 421
Better than 6% of the companies in the industry
Equity−DKK 7.1mNo. 391 of 431
Better than 9% of the companies in the industry
Number of employees5No. 290 of 431
Better than 33% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,658of 69,742
Better than 0%
No. 69,410of 69,964
Better than 1%
Same industry and fewer than 20 employees329 companies in the comparison
No. 311of 323
Better than 4%
No. 300of 329
Better than 9%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,515of 33,588
Better than 0%
No. 33,233of 33,687
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 66,297of 66,379
Better than 0%
No. 65,951of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Lophora ApS−DKK 11.7m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Lophora ApS−DKK 10.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Lophora ApS−DKK 7.1m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Lophora ApS5
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Commerce Pharma Holding ApS20%
  • Timothy John Haines5%
  • Anders Asbjørn Jensen15%
  • Emil Märcher-Rørsted15%
  • Jesper Langgaard Kristensen20%
Lophora ApS

Management

4 active registrations

Executive management

Executive management at Lophora ApS
NameRoleAppointed
Bo TandrupCEO17/09/2018
Jesper Langgaard KristensenDirector12/01/2021

Board of directors

Board of directors at Lophora ApS
NameRoleAppointed
Ian Rodney LaquianChair of the board12/01/2021
Joseph Donald deBethizyBoard member12/01/2021
Founders
Bo Tandrup, Anders Asbjørn Jensen, Emil Märcher-Rørsted, Jesper Langgaard Kristensen

Signing rule: Selskabet tegnes af en direktør sammen med bestyrelsesformanden, eller af den samlede bestyrelse.

Address and production units

2 active production units

Herlev Hovedgade 195A
2730 Herlev

Herlev Municipality · Postcode 2730

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
Lophora ApSGyldenlundsvej 21, 1, 2920 Charlottenlund51023964976
Lophora Pharma ApSHerlev Hovedgade 195A, 2730 Herlev11031641671

Purpose

Virksomhedens formål er at forske og udvikle lægemidler til behandling af psykiatriske sygdomme.

The purpose is quoted from the register in Danish.

Changes year by year

54 registered events
20262 changesaccounts 1 · address 1
  • Annual report for 2025 published
  • Moved to Herlev Hovedgade 195A, 2730 Herlev
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changescapital 1 · ownership 6 · accounts 1
  • Share capital changed from 51,436 DKK to 63,313 DKK
  • Jesper Langgaard Kristensen registered as owner (20%)
  • Emil Märcher-Rørsted registered as owner (15%)
  • Anders Asbjørn Jensen registered as owner (15%)
  • Anders Asbjørn Jensen is no longer registered as owner
  • Emil Märcher-Rørsted is no longer registered as owner
  • Jesper Langgaard Kristensen is no longer registered as owner
  • Annual report for 2023 published
20232 changescapital 1 · accounts 1
  • Share capital changed from 50,390 DKK to 51,436 DKK
  • Annual report for 2022 published
20222 changesaccounts 1 · address 1
  • Annual report for 2021 published
  • Moved to Gyldenlundsvej 21, 1, 2920 Charlottenlund
20216 changesindustry 1 · address 1 · accounts 1 · management 3
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
  • Moved to Lersø Parkallé 107, 2100 København Ø
  • Annual report for 2020 published
  • Ian Rodney Laquian appointed chair of the board
  • Jesper Langgaard Kristensen appointed director
  • Joseph Donald deBethizy appointed board member
202015 changescapital 2 · ownership 12 · address 1
  • Share capital changed from 47,871 DKK to 50,390 DKK
  • Timothy John Haines registered as owner (5%)
  • Share capital changed from 40,014 DKK to 47,871 DKK
  • Bo Tandrup registered as owner (20%)
  • Bo Tandrup is no longer registered as owner
  • Anders Asbjørn Jensen registered as owner (20%)
  • Emil Märcher-Rørsted registered as owner (20%)
  • Jesper Langgaard Kristensen registered as owner (25%)
  • COMMERCE PHARMA HOLDING ApS registered as owner (20%)
  • Bo Tandrup is no longer registered as owner
  • Anders Asbjørn Jensen is no longer registered as owner
  • Jesper Langgaard Kristensen is no longer registered as owner
  • COMMERCE PHARMA HOLDING ApS is no longer registered as owner
  • Emil Märcher-Rørsted is no longer registered as owner
  • Moved to Ole Maaløes Vej 3, 2200 København N
201910 changesname 1 · capital 1 · ownership 8
  • Name changed from Lophora IVS to Lophora ApS
  • Share capital changed from 1,000 DKK to 40,014 DKK
  • Bo Tandrup registered as owner (20%)
  • Anders Asbjørn Jensen registered as owner (25%)
  • Jesper Langgaard Kristensen registered as owner (25%)
  • COMMERCE PHARMA HOLDING ApS registered as owner (20%)
  • Bo Tandrup is no longer registered as owner
  • Anders Asbjørn Jensen is no longer registered as owner
  • COMMERCE PHARMA HOLDING ApS is no longer registered as owner
  • Jesper Langgaard Kristensen is no longer registered as owner
20187 changesfounded 1 · management 1 · ownership 5
  • Registered as Lophora IVS
  • Bo Tandrup appointed ceo
  • Bo Tandrup registered as owner (10%)
  • Anders Asbjørn Jensen registered as owner (33.33%)
  • COMMERCE PHARMA HOLDING ApS registered as owner (10%)
  • Jesper Langgaard Kristensen registered as owner (33.33%)
  • Emil Märcher-Rørsted registered as owner (20%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction